PrimeRFP SCOUT · Federal Contract Profile

Isola Therapeutics (M3QDM72NME75)Federal contracts

Isola Therapeutics holds $8.2M in federal volume across 3 awards, with 100% at Department of Health and Human Services (HHS). Primary work: Research and Development in Biotechnology (except Nanobiotechnology) (100% prime). Obligations are down 100% year over year, FY2024 vs FY2023.

$8.2M
Federal Volume (36mo)
0
Recompetes (24mo)
HHS
Top Agency · 100% firm-wide
3
Awards

Choose one — this changes what we ask next

Score my firm against Isola Therapeutics

One email. We send the overlap and watch their recompetes.

Choose one — this changes what we ask next

36 months through Jun 30, 2026.

Why are you looking at Isola Therapeutics?

Score my firm against Isola Therapeutics

One email. We send the overlap and watch their recompetes.

What they do

Capability

Service lines

RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Work mix: 100% prime · 0% sub · primary NAICS 541715 / PSC AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT

Where they win

Sole agency
Sole agency: Department of Health and Human Services (HHS) · % of firm-wide obligated ($8.2M)

Recompete exposure: None

SCOUT does not currently show incumbent recompetes for Isola Therapeutics in the next 24 months.

This page already speaks for you

Recompete exposure & trajectory

Recompete exposure

None

SCOUT does not currently show incumbent recompetes for Isola Therapeutics in the next 24 months. As of Jun 30, 2026.

Dollars in this list are current contract value: base plus exercised options. The totals above add that same figure.

The rest of this firm’s 24-month recompete book is not on this page yet. Open the live SCOUT company view.

Trajectory
▼ Consolidating-100% YoYFY2024 vs FY2023
'23
'24
“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”
— Shauna Weatherly, FedSubK
Explore another company
Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Isola Therapeutics hold?

Isola Therapeutics (UEI M3QDM72NME75) shows $8.2M across 3 awards in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K over 36 months through Jun 30, 2026.

How much in federal contracts does Isola Therapeutics have?

Isola Therapeutics shows $8.2M across 3 awards.

Which agencies does Isola Therapeutics work with?

Isola Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).

What is the UEI for Isola Therapeutics?

The Unique Entity ID (UEI) for Isola Therapeutics is M3QDM72NME75.

A row is the PIID, the date, and the current contract value.
SCOUT Durability is the read on that contract: six facts and the patterns they flag. Ten reads are the FY27 Sprint Pack, $2,800.

The Pack is ten Pursuit Analyses in a 12-month balance. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Sources: USASpending, FPDS, SAM.gov · Data shown is public-record; analysis by PrimeRFP SCOUT. Data through Jun 30, 2026.
primerfp.com/intel/company/isola-therapeutics-inc